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Abstract
It is possible to distinguish two phases in the development and maturation 
of the intestine: intra-uterine and extra-uterine. 
Up until the 13th week of the embryological phase, a fetus’ development is 
not controlled by factors external to the alimentary canal. It is instead guided 
by the homeotic genes that control the proliferation and differentiation during 
the embryogenesis.  
A fetus’ interaction with the external environment starts with the 
perforation of the buccal membrane, when the fetus starts swallowing the 
amniotic fluid. Both in pathological and physiological conditions, the 
encounter with the microbiota – that surely happens at birth, but could 
happen before as well – furnishes to the developing intestine elements which 
are necessary and essential to the growth of the organ, the barrier function, 
and the specific and nonspecific immunity. The link between development, 
maturation and inflammation is very important and influences the entire 
intestinal homeostasis. In case of preterm birth, the immaturity of the system 
creates a proinflammatory environment where the tolerance of the commensal 
microbiota cannot be taken for granted, and the maternal milk is not always 
available. These grounds are preconditions for the Necrotizing Enterocolitis 
(NEC). NEC is a calamitous pathology for a preterm baby, able to increase 
mortality, morbidity and the length of hospitalization. 
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This review aims at understanding how to prevent 
NEC. It will do so by analyzing the mechanisms of 
the development of the inflammation at intestinal 
level, and at the level of its regulation. Several 
evidences, both clinical and experimental, show that 
the main form of NEC prevention is the dispensation 
of maternal milk. Maternal milk allows a proper 
growth and development of the intestine, a proper 
settlement of the microbiota, and control over the 
intestinal inflammation. 
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Introduction
The intestine’s development has two distinct 
phases: intra-uterine and extra-uterine. The 
second one is induced by the encounter with the 
microbiota – the normal commensal flora in the 
process of colonizing the intestine – and with the 
antigens found in foods [1].
The intestine needs to encounter the microbiota 
only after having reached a maturity stage that allows 
it to tolerate the bacterial antigens evolutionarily 
known. Those bacterial antigens, the so-called “old 
friends”, are able to stimulate the production of IL10 
and TGFβ, which in turn are deputed to modulate 
the inflammatory response [2].
Evidence suggests that an early encounter 
with the microbiota – an encounter that happens 
when the intestine has not reached an optimal 
maturity stage – is deleterious for the short-term 
development of the intestinal immunity [3]. On 
the other hand, it is worth considering that among 
the germ-free animals it is possible to notice 
that the absence of the normal flora is source of 
morphological and pathological anomalies [3]. 
The microbiota has different functions: it 
influences both the inflammatory response and the 
innate immunity, it activates those pathways able 
to stimulate cell proliferation and influences the 
ecology of the Crypts of Lieberkühn [1, 3]. 
Some questions arise now, concerning – in 
a pattern of normal development – how the 
microbiota and the diet influence the intestine’s 
maturity, what are the mechanisms that lead to 
the alteration to the normal development which 
rouse the inflammation producing the Necrotizing 
Enterocolitis (NEC), a calamitous pathology for a 
preterm baby, able to increase mortality, morbidity 
and the length of hospitalization [3].
In-utero intestinal development
Embryonic period
When we speak of embryonic development, 
we refer to both the gestational period and the 
Carnegie stages [4, 5], which divide the embryonic 
development into 23 morphogenetic steps that 
allows a quick comparison of the development of 
species with different gestational lengths. 
The embryonic development begins from 
an undifferentiated totipotent cell, the zygote, 
that divides itself while maintaining identical to 
itself until the blastocyst stage (Carnegie stage 3, 
reached by humans on the 4th or 5th day). 
The blastocyst cells are defined as “pluripotent”, 
for they are able to originate all the tissues that 
form the organism, but not the organism in its 
integrity. When the embryo differentiates into its 
three germ layers and with its folding, the cells 
are progressively differentiated losing their initial 
plasticity. This process is guided by the Homeobox 
genes, also called homeotic genes [6].
The Homeobox are genes which encode factors 
for nuclear transition, and are involved in the 
regulation of the embryonic development. They are 
characterized by a sequence around 180 base pairs 
long, highly conserved across different species, 
and have been first studied in the Drosophila [7, 
8]. They act by regulating the transcription of 
the target genes and direct the organogenesis 
[9]. Every organ is specified by a “cocktail” of 
homeotic genes products, combined in quotas 
which have a regional difference according to 
gradient of concentration which vary during the 
course of the time [10].
An homeotic signal triggers a series of genes 
able to duplicate and transform the cell. For 
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this reason, the same signal, under the action 
of the following replication, acts on a different 
microenvironment. It gradually stimulates the 
production of other factors that keep modifying 
it, up until the creation of a cellular environment. 
Here, in this protect environment, the final 
multipotent stem cell is able to renovate itself and 
to produce mature cells – in few words, to do its 
work [11, 12].
Thus, under the Homeobox guidance, from the 
germ layers are first formed the organs, and then a 
pool of stem, multipotent, cells. Those are organ-
specific, have a limited plasticity, are able to provide 
for the cell renewal and the organ maturation [6].
Stem cells niches are then developed in every 
organ. Those niches are needed because they 
allow the stem cell to remain so, giving place 
to a differential replication: a portion of cells 
differentiates, the other remains stable. This is 
made possible also by the presence of ancillary 
cells. The ancillary cells, producing growth factors 
and protecting stem cells, are essential to their 
subsistence [6]. 
At the second week of development (11-13 
days of gestation, Carnegie stage 5) the embryo’s 
body is a disc composed by two germ layers 
(hypoblast and epiblast) suspended between the 
yolk sack and the amniotic cavity. The process 
called “gastrulation” takes place at Carnegie stage 
6 (17 days of gestation for the human embryo) [5, 
11]. The epiblast cells differentiate, and form the 
primitive streak, a groove that cuts in half the body 
of the embryo, providing a rigid axle, around which 
the embryonic folding occurs, and through which 
migrate the cells which go to great lengths under 
the hypoblast. At this point, a trilaminar embryo is 
now formed. Its body is composed by three germ 
layers, from the amniotic cavity to the yolk sack: 
ectoderm, mesoderm, endoderm. 
At Carnegie stage 8 (23 days of gestation) 
the epiblast specifies for the mesoderm and the 
endoderm. It does so because of the combined 
action of two Homeoboxes: MIXL 1 (Mix Paired 
Like 1 Homeobox) and NODAL, and the activin A.
More precisely, the cells that react first at the 
MXL 1, react more to the activin A and NODAL, 
generating the endoderm of the anterior intestine, 
and the precursors of liver and pancreas. Those in 
turn express the TGFβ (Tumor Growth Factor β)
and genes related to the endoderm. On the other 
hand, the cells that react slower and to a higher level 
of MIXL1 (and that express FOXH1 – Forkhead 
box H1 – and GSC – Goosecoid Homeobox – in 
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order to block its action [16]) react then to NODAL 
stimulation, producing a mesenchymal phenotype 
[13-16]. 
The Endoderm then stimulates the mesoderm to 
produce the SHH (Sonic Hedgehog) which in turn 
stimulates the endoderm to produce WNT (Wingless 
Nuclear Transcription Factor). In this phase WNT, 
a protein which is cardinal to the preservation of a 
pool of stem cells in the mature intestine, promotes 
the proliferation of the primitive intestine and its 
elongation, on the cranio-caudal axis of the embryo. 
The primitive intestine is instead a very important 
structure from which most of the thoracic and 
abdominal organs origins [5, 10, 12, 17]. 
The specification of the primitive intestine 
to the anterior intestine begins at Carnegie stage 
10, thanks to high concentrations of WNT in the 
cephalic area, while the prevalent BMP signal in 
the caudal area triggers the intestinal differentiation 
in the middle and posterior intestine.
At this stage, there are then 3 regions in the 
caudal-cranial axis: anterior, middle and posterior 
intestine. From the anterior intestine originate the 
pharynx, the upper respiratory tract, the esophagus, 
the stomach, the duodenum, the liver, the 
pancreas, and the biliary system. From the middle 
intestine arise the small bowel and the caecum, the 
appendix, the ascending colon, and the proximal 
traverse colon. From the posterior intestine come 
the other parts of the colon, the rectum, and the 
anus [17-19].
The mesoderm develops together with the 
endoderm, and while from the latter derive the 
supporting connective tissue, from the former the 
neural crest originate the enteric nervous system 
[17, 18]. Now, a trilaminar embryo is formed.
There are three mechanisms that not only 
maintain the regional identities of the portions of 
the primitive intestine, but also guide the process of 
differentiation [12]: the combination in gradient of 
different transcriptional factors, the cell positioning, 
and the cell’s sensitivity to those factors that come 
from cells of a different germ line. 
In the development of the intestine, the pro- 
liferation, differentiation and cells placement are 
the result of an intense exchange between the 
endoderm, forming the epithelium, and the under- 
lining mesenchyme [10, 12].
Regulation of the intestinal embryogenesys 
The most important signals that regulate the 
intestinal development are: 
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r Hedgehog and PDGF (Platelet Derived Growth 
Factor). Originating from the epithelium, those 
signals act on the underlining mesenchyme. 
These elements regulate the differentiation 
of the myofibroblasts and of the smooth 
muscle cells, and at the same time activate the 
cascade of transcriptional factors regulating the 
production of WNT and BMP [11, 12, 15].
r WNT and BMP operate on the epithelium, to 
regulate the differentiation and proliferation 
[11, 12], and are mutual antagonists because 
both have as a target the control of the activities 
of the transcriptional factor β-catenin. WNT is 
mainly expressed in the cephalic portion of the 
intestine, while the BMP I by the caudal one 
[11, 12].
r FGF (Fibroblasts Growth Factor) shows the 
same gradient as the BMP, that is to say that 
it grows from the cranial towards the caudal 
region, and regulates the transcriptional factors 
triggered by the retinoic acid, such as the 
HoxB1 (Homeobox B1) and the HoxA5 [20].
In the cranial region, every organ between 
the mouth and the duodenum – such as liver and 
pancreas – comes from the anterior intestine. The 
first specification step is the activation of FOXA2, 
by WNT and NODAL. 
Other molecules, the list of which is always 
increasing, intervene after the FOXA2. Those 
molecules specify as the forerunners for the 
developing organs. Those are: HHEX, that 
specifies the liver and is activated by NODAL and 
WNT), SOX17 (cardinal for the pancreas’ early 
differentiation, activates PDX1, but also – with 
WNT, FOXA2), CDX2 (Caudal type Homeobox 
2) responsible or the specification of the middle 
and posterior intestine and allocated from the 
duodenum downward [12].
In the caudal region, that is, the middle and 
posterior intestine, the essential gene for the 
development of the intestine is CDX2. It is 
expressed by the junction between the anterior and 
the middle intestine and allows the differentiation 
of the progenitor cells of the intestinal epithelium. 
At a second moment, it is added to this signal, that 
of the SOX17 – Sex determining region 17 [2].
CDX2, WNT, and BMP are then important 
during the fetal period the maturation of the 
intestinal epithelium. They are important to 
establish the differentiation between the crypt 
and the villus, between the epithelial area and 
the intestine’s proliferation and modeling, after 
the closing of the “pipe” [10, 12]. This process is 
schematized in the Fig. 1. 
At the 12th week of gestation, in humans the 
macroscopic differentiation of the primitive 
intestine is complete, with the presence of several 
buds: lungs and respiratory tree, liver, pancreas 
Figure 1. Intestinal embryogenesis and principal homeotic genes.
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and alimentary tract [5]. The last one is a tube 
that goes from the mouth to the anus, and has 
undergone a series of bending and rotations, 
which have allocated it in both the thorax and the 
abdomen [5, 12]. Also this process of allocation is 
guided by the Homeobox products, the gradient of 
which regulates the left-right axis and the rotations 
both [21].
The intestinal lumen, around the 6th week 
is obliterated by the cellular proliferation, but 
subsequently – from the 7th week onwards – a 
process of recanalization starts, and the formation 
of the villi, of the crypts, and the process of cellular 
differentiation.
Fetal period: controlling signals for the in-utero 
maturation of the intestinal epitelium
The maturation of the intestinal epithelium 
happens after the end of the embryogenesis. 
The last two steps of the intestinal em- 
bryogenesis are the formation of the villi, starting 
at around the 7th week (Carnegie stage 19) and 
continuing with the formation of the crypts up 
until the end of the 8th week (Carnegie stage 23). 
The secretion of the SHH from the cell of the 
epithelium of the primitive intestine induces in the 
mesenchyme the differentiation of the first level of 
circular muscle. It is then thus generated an elastic 
tension that raises the epithelium in folds [22]. 
This play of signals between the mesenchyme and 
the epithelium continues until the formation of the 
layer of longitudinal muscle, on the outside of both 
the circular muscle (which raises the zigzag folds) 
and the muscolaris mucosa (which induces the 
formation of the villus) [22]. 
The folding of the epithelium during the 
formation of the villi has a secondary effect: it 
concentrates the BMP signal on the villus’ apex 
[23]. BMP, from the epithelium, induces the SHH 
from the mesenchyme, which in turn inhibits the 
WNT around the villus, leaving it on the bottom.
This way, the WNT/BMP axis is created. It 
divides the intestine into two areas: the crypt – the 
portion of active replication – and the villus – where 
the mature cells execute their functions [23].
The villi can also be produced in absence of the 
smooth muscle, but when this happens, it happens 
in a disorderly fashion, caused by physical reasons 
(because of the elastic compression from the 
mesoderm on the endoderm [22]) as well as by the 
absence of exchanges between the mesenchyme 
and the epithelium [23].
When the villi are formed, the crypt-villus axis 
is established, and the SHH, WNT, BMP start 
the differentiation of the cells of the endoderm 
[24, 25]. 
The cellular differentiation is schematized in 
Fig. 2.
The balance between WNT and BMP has a 
target: the β-catenin. The β-catenin is a nuclear 
transcriptional factor: it moves inside the nucleus 
activating the T cell factor/lymphocyte enhancer 
factor (TCF/LEF), which in turn activate the 
transcription of genes connected to the cellular 
proliferation. WNT has numerous final targets, 
mostly described in the studies on the colorectal 
tumors [26]. WNT, by activating NOTCH, is 
able to limit itself. When this happens, the stem 
cell rises from the bottom of the crypt and starts 
a process of differentiation that requires the BMP 
and the PI3K [24, 27, 28]. 
The signals that give origin to the different cells 
of the intestinal epithelium are synthesized in Fig. 2. 
The crypt is a saccular pocket that stays between 
two villi. Because of its morphology it remains 
relatively protected from environmental stimuli, 
apoptosis and differentiation. It is surrounded 
externally by the pericryptal fibroblast [29] and by 
the mesenchyme while at the inside it is covered 
by an epithelium composed by 10 Paneth cells 
and 15 intestinal stem cells, multipotent and non-
committed [29, 30]. For this reason the crypt is 
an anatomical structure that functions as a stem 
cells “reservoir”, where they can be held, ready for 
the intestinal regeneration. The multipotent cells, 
commonly known as CBC (Crypt Base Columnar) 
are posed at the bottom of the crypt. They are 
characterized by the presence of the LGR5 
receptor, which is able to strengthen the signal 
of the WNT [19, 31-33]. Normally the division 
of the CBCs is asymmetric: an identical daughter 
cell and a committed one [32], but there can also 
be a variation due to environmental causes such 
as the exposition to radiation, or to chemotherapy 
[29, 32].
Because the space in the crypt is limited, the 
CBC in active replication is pushed upwards 
and loses contact with the Paneth cells [34, 35]. 
This happens in 2-3 days, 6-7 replications. The 
replicating cells place themselves at the junction 
between the crypt and the villus, giving place to the 
TA cells, “transient amplifying cells” [19, 27, 29]. 
Those – also called +4ISC because of the position 
inside the crypt – are cells ready to differentiate in 
every mature line of the intestinal epithelium [29]. 
Embryological development of the intestine and necrotizing enterocolitis
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From them all the mature cells of the intestinal 
epithelium (Fig. 2), together with the Paneth cells, 
originate. While the formers direct themselves to 
reassemble the villus’ axis, and are quickly (in a 
3 days’ time) exfoliated and substituted, the latter 
migrate toward the bottom of the crypt, and can 
remain there for up to a month. The proximity to the 
WNT-producing Paneth cell is the most essential 
requirement for maintaining the pluripotency of 
the CBC/LGR5+ cell, so that, when the Paneth 
cells are removed, also the LGR5+ are lost [30, 34-
37]. The mature intestinal epithelium is composed 
by 90% of enterocytes with absorbing function, 
and for the remaining 10% by endocrines, Paneth, 
and M cells [3]. With the differentiation of the 
enterocytes, those structures are formed which 
guarantee to the intestine the possibility to fulfill 
its function of non-immunological barrier. 
The term “non-immunological barrier” de- 
scribes the ability of the intestinal epithelium 
to defend itself from the encounter with the 
environmental pathogens, and avoid their passage 
into the bloodstream. 
The non-immunological barrier is made possible 
by the brush border of the enterocytes, by the 
adherence to the submucosa, by the intraepithelial 
tight junctions, by the mucous layer secreted by the 
goblet cells [19, 30, 38]. The mucous in particular 
contains dietary antigens, captures pathogenic 
bacteria. His production rapidly increases as a 
reaction to insults and presents multiple binding 
sites for chemokines, growth factors and cytokines. 
This barrier protects both the villus (the mature 
component of the intestine) and the crypt [30, 38].
The embryo begins swallowing at around 
the 11th gestational week [39]. The contact of 
the intestine with the amniotic fluid (containing 
cytokines regulating the immune response, stem 
cells, growth factor etc. [39-42]) has an impact on 
the maturation and on the cells growth, both at the 
end of the embryogenesis, and during the entire 
fetal period. In addition, many of the factors in 
breast milk are also present in the amniotic liquid. 
It is possible to theorize that this functional overlap 
between the amniotic liquid and the breast milk 
prepares the intestine to the passage from a secure 
environment of the womb to an exposed one. [43-
50]. It is possible that the bioactive properties of 
the amniotic liquid are able to influence also the 
immediate postnatal development of the preterm’s 
intestine [40]. There is much experimental evi- 
dence to support this hypothesis. 
Figure 2. Epithelial cells differentiation.
Modified from Kandasamy et al., 2014 [3].
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The ingestion of amniotic liquid, rich in EGF, 
inhibits the expression of the TLR4, responsible 
for the inflammatory response, in fetuses [39] and 
promotes the maturation and the development of the 
intestine thanks to the EGF and the other growth 
factors such as the IGF-1, FGF, HGF, and TGF-α, 
the same that can be found in breast milk [41].
The amniotic liquid is rich in stem cells [40]. 
In the presence of chorioamnionitis, the ingestion 
of infected amniotic liquid has a very heavy 
impact of the intestinal epithelium. It triggers the 
inflammatory cascade provoking an intraepithelial 
leukocyte chemotaxism, loss of the tolerance 
secretion of TNF and interferon γ and upregulation 
of Toll Like Receptors 1, 2, 4, 6 (surface receptors 
used for the recognition of a pattern of molecules 
common to different microbes).
The proliferation of the crypts diminishes 
during the acute phase, to grow again immediately 
after. 
The tight junctions are inhibited, and the 
function of intestinal barrier is thus lost [42].
Postnatal maturation of the intestine
In order to complete its maturation the intestine 
needs to be colonized and nourished. This can 
only happen outside the utero. Let us consider the 
development of the different intestinal functions (as 
immune and non-immune barrier, motor function, 
or digestive) while in physiological condition. By 
physiological condition is intended an intestine 
mature enough to be able to interact with the breast 
milk and the microbiota maintaining a condition 
of homeostasis without triggering an inflammatory 
response.
Development of the barrier function 
 
The microbiota
It is thought that the first encounter between 
the intestine and the microbiota happens during 
the passage through the birth canal, and with 
the nursing afterwards [38]. There are, however, 
many recent studies on the placental microbiota 
from which it seems that already during the fetal 
period the intestine is colonized, in both normal 
condition and in presence of chorioamnionitis [42, 
51]. Anyhow, regardless of when the colonization 
takes place, it is thought that it permanently affects 
the intestinal immunity, and by reflex, the entirety 
of the organism [3]. 
The composition of the microbiota changes 
enormously, both among different animal species, 
and among individuals inside the same specie, and 
it is subjected to the influence of a great number 
of external stimuli. [52]. We can affirm that each 
individual lives with its own microbiota, which 
influences the individual phenotype [53, 54]. 
However, if the bacterial classification is considered, 
and the colonization patterns are confronted at the 
Phyla level, instead of at the Genera level, communal 
pattern of colonization will be found, which will 
make it possible to comprehend different phenomenon.
4 Phyla are predominant in the human intestine: 
Bacteroidetes, Firmicutes, Actinobacteria and 
Proteobacteria [55]. In a newborn, some phyla are 
less represented [53]. The commensal microbiota is 
symbiotic with the human organism: it influences its 
health and disease, intestinal development, immunity 
response, and metabolism [55]. 
To remain commensal, and therefore symbiotic, 
without becoming a pathogen, the microbiota has to 
satisfy a couple of rules: there must be an equilibrium 
between the different Phyla, an equilibrium otherwise 
known as “eubiosis” [56]. Moreover, the bacteria 
have to remain at the level of the intestinal lumen, 
without for it to be possible to invade the tissues or 
arrive near the crypt [27]. 
There are only a few exceptions to this rule, 
and it is often discussed whether the data indicate 
a pathology, giving the fact that they are described 
in pathological as well as healthy models, and 
potentially trigger autoimmunity. 
For example, the SFB (Segmented Filamentous 
Bacteria), which belong to the phylum of the 
Firmicutes, in the Clostridia, or do directly enter 
in touch with the intestinal epithelium, instead of 
the mucous layer. They are able to stimulate the 
production of the IL17 from the T lymphocytes of 
the own lamina, and the secretion of the IL 22 and 
REG3γ in the epithelium, playing a protective action 
over the infection by strains of enterohemorrhagic E. 
coli [57].
A second exception is represented by the “crypt-
specific core microbiota” (CSCM) described in the 
crypt of the caecum and of the colon, where the 
dominant species is an aerobic, non-fermenting, 
bacterium that belongs to Acinetobacter spp. [27, 58]. 
It is unknown whether Acinetobacter spp. indicates 
pathology or is physiological. 
Under physiological conditions the commensal 
microbiota acts in various ways in order to protect 
the body and maintain the state of homeostasis: 
it competes with the pathogenic flora for the same 
Embryological development of the intestine and necrotizing enterocolitis
8/21
Journal of Pediatric and Neonatal Individualized Medicine • vol. 5 • n. 2 • 2016www.jpnim.com Open Access
De Magistris • Marcialis • Puddu • Dessì • Irmesi • Coni • Fanos
metabolites (thus establishing a hostile environment 
for pathogenic elements), it produces antimicrobial 
peptides, receptors and ligands epithelial cells, of 
which the most studied are the Toll Like Receptors 
(TLRs) [59].
A microbiota is sensible to the diet. An excessive 
intake of fat and sugars, for example, triggers 
a disbiosis – that is, an abnormal prevalence 
of a phylum or of a genus inside the microbic 
population, source of a series of intestinal (and 
potentially pathologic) alteration [57, 60]. On the 
other hand, the neonatal immune system integrates 
different signals to promote the homeostasis of the 
system and a normal microbic colonization [27]. 
This is made possible by a series of mechanism 
both immunes and non-immunes, that together 
constitute the intestinal barrier function [55]. 
The intestine of a full-term newborn (as opposed 
to a preterm one) is setted in such a way as to 
accommodate the commensal microbiota, the so-
called “old friends” [2], without reacting (the so-
called concept of the immune “ignorance”) [3, 59].
Probably some factors that are inside the 
amniotic liquid – and in the breast milk – define 
the early responses to the commensals, and the 
intestinal inflammatory response [61, 62]. Thus, 
the intestine is, toward the microbiota, in a state 
of “dynamic balance”. It tries to get the maximum 
benefit from its presence. While on the one end 
it limits its expansion using sophisticated barrier 
mechanisms, on the other end it receives and gives 
stimuli, which also depend on the diet. 
The intestinal barrier 
The intestine has its surface covered by a thin 
monolayer of epithelial, multifunctional, cells with 
highly immunoreactive sub-mucosae. The inter- 
ruption of this barrier may have numerous negative 
consequences, such as the systemic inflam- 
mation, autoimmune and allergic diseases [63-68]. 
The quantity and quality of the bacteria that arrive 
at the intestinal lumen is controlled by a series of 
barrier, both chemical and physical, located over it 
[69, 70]. Those barriers are: the mucous membrane 
surrounding the respiratory tract, which contains 
a series of enzymes and other substances with 
direct antimicrobial action, as well as microbial 
anti-adherence; the secretion of acid by the gastric 
enterochromaffin cells, bile salts produced by the 
liver, and the release of proteolytic enzymes from the 
pancreas. The antigen load that reaches the intestine 
is damped and controlled by all these factors, in 
order to prevent hematic passage and maintain the 
homeostasis between the intestine’s inflammatory 
and anti-inflammatory activities. Virtually all com- 
ponents of intestinal epithelium combine to create the 
so-called “mucosal firewall” [59].
The components of the innate mucosal form a 
physical barrier that goes from the luminal surface 
to the basal membrane, passing through the cell 
layer, which does not allow direct contacts between 
epithelial cells and microbiota [71]. 
When in touch with the luminal surface [71] 
the antimicrobial peptides, produced by cells of 
Paneth and the enterocytes, are placed in contact 
with the mucous layer. Their production can be 
either inducible or constitutive. 
The main products are lysozyme, defensins, 
cathelicidin and angiogenin. Cathelicidin and an- 
giogenin are able to destroy the microbial wall 
(Tab. 1) [3, 19, 38]. 
IgA are initially given to the baby, for at 
least the first two weeks of life, via breast milk 






Angiogenin x x x
Cathelicidin x x x
β defensins x x x
Paneth cells
α defensins x x x
PLA2 x x x







Table 1. Antimicrobial peptides.
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[59]. Together with the antimicrobial peptides – 
produced by the epithelial cells – they cover the 
mucous layer and are essential in their interaction 
with the microbiota. They activate the complement 
and promote the phagocytosis [72]. 
Their deficiency causes dysbiosis, an increase in 
SFB – that is potentially pathological [55] and leads 
to the expansion of the bacteria associated with the 
mucosa such as segmented filamentous [57].
The mucous layer which is secreted by the 
goblet cells is located immediately below the 
antimicrobial peptides and IgA, and it is formed by 
different kind of mucins with specific functions. 
Indeed there are soluble mucins, gel forming 
mucins, and those with the function of anchoring 
to the membrane [73].
The mucins present multiple binding sites 
for the active molecules, both for inflammatory 
regulation (cytokines) and the epithelial growth 
(growth factors).
Small nutrients pass through the mucous layer, 
but dietary antigens – together with pathogens – 
are trapped there.
The mucus production – together with its 
composition – changes with the postnatal age. It 
happens in response to the bacterial challenge, 
after the colonization of the commensal microbial 
flora and during the process of epithelial shelter 
[70, 73].
The cellular elements that make up the intestinal 
barrier are: all the cells of epithelial origin, the 
mast cells, the dendritic cells, the phagocytic cells 
(macrophages and granulocytes), the Nk cells, 
and the γδT cells [71]. They communicate via a 
tight network of signals, adhere to the submucosa 
through the integrins, and to one another by tight 
junctions [69, 70].
It is a sophisticated system of junctions, from 
the apex to the bottom of the cell, which ensures 
a certain degree of paracellular passage, which is 
both physiological and needed for the development 
of the immune system [52].
In this way it is ensured a semipermeability to 
the cell. This means that the passage of the bacteria 
into the circulation is restricted, together with that 
of a myriad of other luminal macromolecules. 
At the same time, both the transcytosis and the 
absorption of macromolecules generated during 
the normal processes of digestion are promoted. 
The immaturity in the composition and in the 
function of tight junctions, gives a reason – 
especially in prematures – for the increased 
intestinal permeability [69].
The subepithelial components of the mucosal 
barrier include a series of immune cells that 
explain the intestinal adaptive immunity. They 
are: macrophages (phagocitizing the commensal 
bacteria able to pass through the epithelial barrier, 
but not the pathogens [55]), dendritic cells (APC, 
antigen-presenting cells, necessary to regulate 
antibody production and the cell-mediated im- 
munity), myofibroblasts, lymphocytes T and B. 
The lymphocytes T and B, in particular, once 
matured (due to the contact with the antigen on 
the Peyer’s patches and the lymphoid follicles) are 
placed in the basal membrane and hence secrete IgA 
specifications that cover the intestinal barrier [71].
Dialogue: how the microbiota influences the intestinal 
development
MAMPs receptors 
Up to now, two classes of receptors for bacterial 
products are known, those present on the cell 
surface (TLRs) and intracytoplasmic ones (NOD). 
The role of the latter in the genesis of intestinal 
disease of prematurity is discussed [74, 75]. They 
are diffused on the epithelium of the villi and 
crypts, and on the cells of the immune system, 
and trigger a series of intracellular pathways, and 
are assigned to the recognition of the MAMPs 
(“microbe-associated molecular patterns”) [27].
They are therefore able to activate the innate 
immunity, responding to the stimulus given by 
one or more molecules similar but not identical 
between the different microbes. For example, the 
TLR4 interacts with bacterial lipopolysaccharides 
(LPS) [76].
The TLRs triggers inflammation through the 
activation of NfκΒ, and then the production of 
antimicrobial peptides, adhesion molecules, and 
acute phase proteins [43, 77].
The most important TLRs for a newborn’s 
intestine are TLR9 and TLR4 [77].
TLR4 is responsible for responding to bacterial 
endotoxin, long chain lipids produced by bacteria, 
FFA (Free Fatty Acids), and other substances, 
such as PAF (Platelet-Activating Factor) [78-82] 
and it is thought to play an essential role in the 
pathogenesis of NEC [76, 77, 83].
Over the intestinal mucosa, the TLR4 activates 
the inflammatory cascade, the NFκB signal, 
and the transcription of TNF and IL1β [77]. It 
also plays other roles that have not been studied 
yet [1].
Embryological development of the intestine and necrotizing enterocolitis
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TLR9 – homologous of TLR4 – recognizes the 
viral and bacterial DNA [76]. Once activated, it 
downrates the expression of TLR4 and decreases 
apoptosis.
The full-term infant’s TLR induces a less-
powerful response to known antigens than that of 
an adult. It is probable that this is a mechanism 
that promotes ignorance against commensal 
bacteria, as the early response to known antigens 
(e.g., LPS) affects the cells of the epithelium into 
becoming hypo-responsive to the same subsequent 
stimulations [59].
In preterm infants, especially in the most 
extreme prematurity, the response is stronger 
than in term newborn, because the intestinal 
epithelium expresses a great deal of TLR4 [76, 
77]. In utero, starting from the 29th week the TLR4 
are washed away by the contact with the amniotic 
fluid, and are part of the underlying reason for the 
proinflammatory environment of the intestine of 
the extremely preterm infant [39].
The Paneth cells
The presence of microorganisms in the intestinal 
lumen induces the production of antimicrobials 
peptides (such as the α-defensin) by the Paneth 
cells, and the enterocytes [19, 38].
Paneth cells are essential for the entire 
intestinal homeostasis. Defined as “sedentary 
neutrophils” [84], they are placed in a strategic 
position: the bottom of the crypt, very close to the 
base of the vessels that supply blood to the villi 
[85]. So, they are subjected to multiple stimuli 
from the bloodstream/hematic circle. They secrete 
WNT. The WNT promotes cell proliferation, 
and provides an essential environment for the 
maintenance of stem cells pool [85]. It has 
been demonstrated that the stem cell matures 
when – pushed upwards in replicative phase 
– it moves away from the Paneth cells [30, 32]. 
The Paneth cells also provide the intestine’s 
first line of protection by secreting a number of 
antimicrobial peptides: lysozyme, α-defensin 
5 and 6 (HD5 and HD6), phospholipase A2 
(PLA2, which activates the PAF), and angiogenin. 
The antimicrobial peptides are constitutively 
produced, but their production increases with 
cholinergic and microbial stimulation (via TLR 
and NOD receptors) [52]. It is unknown whether 
the interaction with the bacterium occurs by direct 
contact, or how else. Further studies are needed. 
The secretion of granules containing antimicrobial 
peptides probably occurs under the stimulus given 
by the activation of the receptor NOD2 [52, 86-
88] that activate NFκB. Angiogenin, induced by 
the microbiota, has probably a role in the capillary 
network development [89]. The α-defensins (HD5-
6), produced via the WNT/TCF pathway, are the 
most specific products of Paneth cells [90, 91].
The HD5 and HD6, specific to the Paneth cells, 
start to appear approximately at the 24th gestational 
week. Under physiological conditions, in adults 
they are more concentrated than in the newborn 
[52]. They undergo a physiological increase over 
the weeks, and are regulated by microbial and 
antimicrobial stimuli [90].
For example, the administration of amoxicil- 
lin induces the down-regulation of several 
different genes in the rat’s Paneth Cells, coding 
for antibacterial peptides, such as defensins, 
matrilysin, and phospholipase A2, MHC (Major 
Histocompatibility Complex) I and II [92]. 
The dysbiosis is also due to impaired production 
of HD5 and HD6. Studies on the intestinal flora in 
patients with Crohn’s disease have shown a link 
between adhesion of E. Coli strains of the ileal 
mucosa, and the increased production of HD5 and 
HD6 [93-95]. Paneth cells are equipped with TLR4 
on the cell surface. TLR4, capable of triggering the 
NFKB cascade (and therefore the inflammation 
and apoptosis), seems to have also been involved 
into the regulation of the cell proliferation [1]. This 
is a first indication that connects the regulation of 
the inflammation to that of cell proliferation.
Interaction between bacterical patterns and cellular surface 
It is unknown how exactly the microbiota 
influences the development. However, from an 
experimental point of view it is evident that it 
does. Studies on germ-free mice have shown that, 
in absence of intestinal microbiota, intestinal 
morphology is generally compromised. The total 
surface of the intestine is significantly diminished: 
the villi are short and the crypts are shallow [52, 
96-99]. The cell renewal is scarce [27, 100, 101], 
the capillary network of the villus axis does not 
develop [89], the maturation of intestinal B 
lymphocytes Th17 – as well as the ratio of Th1-2 – 
are compromised [55]. 
The same changes can be seen in the antibiotic 
treatment [27, 102, 103]. These changes have 
serious repercussions on the integrity of the 
mucosal barrier, and susceptibility to damages 
from toxic and infectious agents [52]. However, 
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they are able to normalize with floral colonization 
or re-colonization.
An important role in maintaining the intestinal 
barrier is played by the composition of the 
microbiota. The dysbiosis alters the expression 
of occludin and zonulin, proteins that form tight 
inter-epithelium junctions, allowing the passage of 
toxins – such as LPS – in the bloodstream. The 
altered permeability of the epithelium is then able 
to trigger an inflammation, in a vicious circle that 
self-amplifies and self-maintains [52, 104-110]. 
Similar changes are also found in mono-colonized 
mice [27, 89, 111]. 
However, alterations of the barrier function 
do not fully justify the profound morphological 
disruption that can be observed in the absence 
of the microbiota, or in conditions of dysbiosis. 
Paneth cells and enterocytes express TLR4, 
CBC, and NOD [27]. The presence of these cell 
receptors on the crypt’s cells is intriguing, and 
makes possible to hypothesize for them a role 
also in the control of cell proliferation. The 
experimental data are still scarce. However, there 
is experimental evidence that by the stimulation 
of TLR4 and NOD – placed at the bottom of the 
crypt cells – it is possible to control the crypt’s 
proliferation [1]. Depending on the examined 
portion of the intestine (duodenum, jejunum, 
ileum, colon) different genes are regulated, 
downstream of WNT: regulating surface proteins, 
cytoskeleton, enzymes, proteins, inflammation, 
etc. Comparing such alteration with those caused 
in MYD88 knockout mice (the MYD88 is part of 
the complex regulatory response to the TLR4), it 
can be seen that a much lower number of genes 
transcribed by WNT is enabled or disabled by 
the absence of this protein. This observation, 
combined with the fact that the MYD88 knockout 
mice do not show alterations in their intestinal 
morphology [112], makes possible to hypothesize 
that the microbiota regulates transcription of WNT 
through more than one pathway. Stimulating the 
microbiota with intra-cryptic LPS has an effect, 
also on cells expressing LGR5, namely the CBC, 
causing apoptosis [113].
Development of the motor function 
The innervation of the gastrointestinal tract 
reaches gradually maturity. The motor pattern – 
that is, the ability to develop effective peristaltic 
contractions, able to advance food from the mouth 
to the anus – starts to mature at the 28th gestational 
week [18, 19, 38]. So the more preterm the baby is, 
the less developed are the motility and bowel tone.
In fact the intestines of a preterm infant is 
characterized by a decreased tone of the lower 
esophageal sphincter, a slow rate of contraction, 
slow stomach emptying and increased residual 
volume.
Intestinal motility is one of the major control 
systems of the intestinal microbiota, for it removes 
the excess of bacteria from the lumen. From its 
immaturity fecal and bacterial stagnation and 
dysbiosis follow, both potentially harmful [38, 114].
Development of the digestive function 
The proteic digestion begins with the hydrolysis 
in the stomach, which is very limited in the VLBW. 
Those do not reach sufficiently high levels of gastric 
pH, and for this reason are also more exposed to 
invasion by pathogens. This situation improves 
between the first and fourth weeks of life [38].
A minor protease capacity means a greater 
number of antigens that reach the intestinal lumen, 
and thus a higher stimulation of gut immunity. 
Intestinal digestion of lipids by the enterokinase 
begins at the 24th week, and matures over time 
[38]. Compared to full-terms, in preterms lipids are 
poorly absorbed [38].
It is not known whether infants can lengthen 
the chain of polyunsaturated fatty acids of more 
than 18 carbon atoms. These are pre-formed in 
breast milk, but not in formula milk. They are 
necessary for intellectual development and have 
different functions. In particular, ω3 have an anti-
inflammatory function and decrease the risk of 
NEC [38]. The digestion of carbohydrates is carried 
out by pancreatic amylase and intestinal lactase. 
This gradually increases between the 24th and the 
40th week (which makes it a marker of intestinal 
maturation). Its activities may be insufficient in very 
young children. The unabsorbed carbohydrates pass 
the intestinal microbiota that forms gas and short-
chain fatty acid (SCFA, easily absorbed) [38].
Hematic flow regulation 
Proper oxygenation is an essential prerequisite 
for the proper development of the intestine, 
and limit inflammation phenomena [72]. The 
blood flow is influenced by metabolic factors: 
the voltage of oxygen and the accumulation of 
metabolic products, which cause vasodilatation and 
endogenous vasodilators, including nitroxide (NO). 
Embryological development of the intestine and necrotizing enterocolitis
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It is secreted by the endothelium, with endothelin 1 
(ET1, a potent vasoconstrictor). Together they are 
able to directly control the operation of the intestinal 
microcirculation, and to maintain homeostasis in 
stress conditions [18, 115].
The efficacy of both mechanisms is partly 
postnatal-age dependent [18]. ET1 is constitutively 
produced, and increases in response to inflammatory 
stimuli and hypoxic-ischemic injury. It has 
angiogenic and vasoconstrictor effects. It has 
at least two ETA receptors, which mediates the 
vasoconstrictor, and ETB. The ET1 tie in ETB 
induces the secretion of NO with which it comes 
in dynamic equilibrium [18, 115]. Both ET1 and 
NO have an effect that varies depending on the 
gestational age. In the newborn, the vasoconstrictor 
tone is predominant, and stimulation of ETB leads 
only to a modest NO dependent vasodilation [115]. 
Therefore, in all conditions where it increases 
the extraction of oxygen (that is under conditions 
of stress, but also after meals) the neonatal late 
response (that is an hyper-flow of blood) is less 
effective the lower the gestational age [18, 115].
Preterm’s typical mucosal alteration
In physiological condition, an infant’s intestine 
at birth is ready to interact with the commensal 
microbiota. The administration of breast milk 
enhances both the interaction, and the formation 
of a commensal, eubiotic microbial flora [19, 38, 
59, 116]. However, premature birth alters these 
premises. With modern techniques of assistance, 
the fetus is viable outside the womb starting 
at 23 weeks of gestational age. Depending on 
gestational age at birth, the intestinal functions 
are more or less mature, and ready for the meeting 
with the microbiota and diet, that influences the 
development.
The immaturity of the general systems strongly 
upsets the newborn’s intestine in a proinflammatory 
sense. In fact, the motor function and the preintestinal 
barrier are not properly developed: the esophageal 
sphincter is not competent, gastric secretions are 
slightly acidic, the production of digestive enzymes 
is short. Because of these reasons, an increased 
bacterial load arrives at the intestine [19, 38].
Vascular tone is set in the vasoconstrictive sense, 
and this does not guarantee adequate perfusion 
under stress conditions [115], extremely frequent in 
a NICU. The lower the gestational age, the greater 
is the production of TLR4, and the lower that of 
TLR9. The former are actively removed from the 
epithelial surface just before the end of physiological 
pregnancy, thanks to EGF in the amniotic fluid [39, 
77, 80].
The production of cytokines is unbalanced in 
the proinflammatory sense [69]. The function of 
intestinal barrier is impaired. This is due to the 
immaturity of all its components: the Paneth cells 
are still not able to secrete a sufficient quantity of 
α-defensins, the mucosal layer is thin and uneven, 
the tight junctions not entirely effective [117]. 
Often, because of the frequent association of 
preterm labor with premature rupture of membranes 
and chorioamnionitis, the intestine of a preterm has 
already been subjected to inflammation in the uterus 
that altered the intestinal permeability, and enhanced 
the physiological proinflammatory, status. So the 
intestinal mucosa of a child born prematurely is 
often hyper-responsive to the inflammatory stimuli, 
even in comparison with a fetus in the uterus of the 
same gestational age [42, 118]. The NICU is a major 
challenge for the mother-child dyad, especially for 
what concerns the possibility of providing breast 
milk: all the components of breast milk so far 
studied have an anti-inflammatory effect, extremely 
valuable for a premature [116]. The formula milk, 
coming to our aid, promotes the development of 
a microbial flora completely different than the 
breast milk, which then does not have the same 
opportunity to be recognized as commensal, and is 
dysbiotic [119]. During hospitalization the baby is 
fed, at least initially, through a nasogastric tube. If 
he is not able to tolerate the feeding, is nourished 
with parenteral nutrition (routine for the preterms). 
Frequently, from the first days of life they are 
given broad-spectrum antibiotics, extremely toxic 
for the commensal flora [120-122]. These are all 
unavoidable factors, affecting bowel function. In 
fact, the growth of the intestine, the height of the 
villi, the mass of the mucosa, cell proliferation, 
mucosal immunity are all indices of intestinal 
health and tissue tropism, are significantly reduced 
by a total parenteral alimentation [123-126]. Often 
these deficits are implicated in the development 
of increased intestinal permeability, bacterial 
translocation and sepsis, and cause increased 
mortality and morbidity [127-129].
Generating necrotizing enterocolitis 
The term Necrotizing Enterocolitis (NEC) 
defines a syndrome where an immature intestinal 
mucosa, slightly tolerant, and in some cases 
already damaged – that could be defined as “ready 
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to sparkle” – responds to stimulation given by 
diet, hypoxia, and by meeting with the microbiota 
triggering a strong inflammatory state, which 
initially involves only the mucosa, and later the 
entire thickness of the wall. 
The natural history of the NEC, if not properly 
treated, goes to intestinal perforation [130].
Despite the association with the impairment of 
the fetal growth, the NEC has never been detected 
in utero [131]. There is no NEC without dysbiosis 
and milk [119, 132, 133].
The only consistent epidemiological risk factors 
for NEC are prematurity and enteral nutrition, 
which may include a rapid progress for diet or 
high osmolarity formula [134, 135]. The NEC is 
also rarely described in a full-term newborn child, 
probably with a different pathogenesis than the one 
of a preterm child. The onset of the disease in these 
children occurs within a few days after birth and 
is often associated with individual risk factors of 
hypoxia-ischemia, like in the cyanotic congenital 
heart disease [72, 136]. Dysbiosis plays a key role 
in the genesis of NEC [120-122]. The intestine of 
an infant – at the beginning of colonization – is 
inhabited by a number of bacterial species lower 
than in an adult subject. The NEC is associated 
with a severe deficiency in the diversity of the 
microbiota, which – favored by empirical therapies 
– can accentuate the impact of dysbiosis, or the 
single dominant microorganism.
To this regard, various data are available. 
[120-122]. In experimental animals, placed under 
stress, administration of LPS induces the NEC; 
moreover, the levels of LPS in the blood and in 
the stool are increased by the NEC [137-141]. One 
study reports that in the week prior to the diagnosis 
of NEC potential known pathogens in the feces of 
79% of the children were found, but there is no 
specific reference to the type of pathogen recovered 
[142]. In another study, patients with NEC showed 
less diversity of bacterial species, an increase in 
the quota of Gammaproteobacteria, a decrease 
in the number of the other species, and received 
more antibiotics compared to controls [121]. In 
controls, bacteria were found from four phyla: 
Proteobacteria (34.97%, in relative abundance), 
Firmicutes (57.79%), Bacteroidetes (2.45%) and 
Fusobacteria (0.54%) with a 4.25% of unclassified 
bacteria.
In the stools of NEC patients only two 
phyla were found: Proteobacteria (90.72%) and 
Firmicutes (9.12%) with 0.16% of unclassified 
bacteria. Subsequent explorations indicate in 
every child with NEC the predominance of a 
single genus of Proteobacteria. The intestine 
of apparently healthy children was instead 
inhabited by different kinds of Proteobacteria, 
in proportions lower than 40%, except in two 
cases (which later developed NEC). The bacterial 
species most frequently placed in relation to the 
NEC were: Klebsiella spp., H. parainfluenzae 
and Pseudomonas spp. [122]. Instead, the species 
normally unrelated are Veillonella spp., E. coli, 
Enterococcus spp., Staphylococcus spp. and 
Enterobacter aerogenes.
Some species are more immunogenic and 
trigger the immune response more than others 
[122]. Probably this difference depends on the 
lipid A, component of the LPS. The activation 
of TLR4 by the LPS depends on the acetylation 
of lipid A [138]. In the adult’s Bacteroidetes, the 
lipid A is usually pentaacylated, and this leads 
to less powerful TLR4 activation and lower 
immunogenicity [140].
In Proteobacteria, lipid A is hexacylated, and this 
makes it a potent agonist of the TLR4. In healthy 
individuals – but not in inflammatory conditions –, 
in eubiosis conditions, the immunogenic properties 
of Proteobacteria are mitigated by Firmicutes and 
Bacteroidetes [141-143].
Dysbiosis, and the peak of Proteobacteria, may 
also cause late-onset sepsis (LOS), secondary to 
altered intestinal permeability [144]. The clinical 
diagnosis of chorioamnionitis, and most importantly 
PROM, increases significantly the NEC risk [145], 
as demonstrated by the association with several 
in utero inflammatory markers [146-150]. The 
anatomy of a newborn’s intestine affected by NEC 
shows a full thickness coagulative necrosis [72], 
enterocytes necrosis, edema [83], lymphocytic 
infiltrate, neutrophils paucity, separation of the 
submucosa and lamina propria, and evidences of 
ischemic damage. The distal ileum and colon are 
more often damaged, but in the most severe cases 
from the stomach to the rectum [83].
The response to microbes is triggered by 
TLR4 [143]. The pathway NFκB, when activated, 
triggers mucosal damage [138], especially when 
prematurity, endotoxemia and hypoxia lead to 
a persistent upregulation of activation of TLR4 
bowel [143]. In the infant’s intestine the TLR4 
regulates the balance between damage and repair 
[139], but also reduces the proliferation and 
migration of enterocytes, as well as the mucosal 
healing [140, 141, 145]. In preterms the TLR4 is 
upregulated, and so the response to the pathogen 
Embryological development of the intestine and necrotizing enterocolitis
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exaggerated [141, 143, 145]. The administration of 
polyunsaturated fatty acids (found – among others 
– in breast milk) appears to have a protective effect 
on the NEC inhibiting the expression of TLR4 
[116].
Animal models for the study of the NEC can 
give a pathogenesis’ idea, even if genetic and 
environmental differences do not allow recreating 
the same condition of the humans.
The main hystopathological models, showing 
NEC like alterations, require a trigger for the 
innate immunity: the model gavage-hypoxia, the 
direct stimulation of TLR4 by administration of 
PAF or LPS, and that of Paneth cell’s [85, 151]. 
In fact the administration of LPS activates the 
TLR4, which are allocated on enterocytes as well 
as on the Paneth cells, then pathogenic pathways 
between these models can be common.
The model of ischemia-reperfusion, instead, 
produces a severe intestinal damage, but not NEC-
like. It seems that the ischemic component, always 
with inflammatory factors – i.e. in hearth disease, 
severe anemia, and transfusions – can favor some 
very serious types of NEC [151].
The first step that leads to the NEC seems 
to be the inflammatory cascade activation via 
the TLR4 and NFκB. It follows the secretion of 
TNF and IL1β and vasoactive substances (PAF, 
ET1, NO), the activation of the complement and 
coagulation cascade the vasoconstriction and 
coagulation necrosis [77]. It is hypothesized that 
the process begins with bacterial translocation, at 
the villus apex. However, even the Paneth cells 
express TLR4, and therefore can be activated by 
the LPS, triggering inflammation and apoptosis, 
and activating complement and coagulation. 
Moreover, they are also placed at the base 
of the crypt (and usually, in the pathologic 
findings, the bacteria settle there), and near the 
endothelium, and are thus capable of controlling 
the homeostasis, inducing the release of PAF, 
ET1, and NO [85].
It is assumed then that the Paneth cell 
dysfunction is the primary cause of the NEC [85].
In support of this hypothesis one can recall 
several observations: first, that the NEC develops 
rarely before a certain degree of adaptive and 
innate immunity maturation, i.e. before 30-31 
weeks of gestational age. So the ELBW have the 
longest presentational interval in the disease [152], 
and it was noted that this might be related to the 
maturation of Paneth cells [85]. In addition, all the 
factors that promote Paneth cells maturation (such 
as lactoferrin, EGF [153-155] and corticoids [156, 
157]) play a protective role against the NEC. 
This hypothesis has not been shared by all 
researchers 
For example Puiman et al. [158] show that 
there is no difference in the number of Paneth 
cells between children operated for NEC and 
those operated for other reasons (such as a case 
of intestinal atresia). In addition, the Paneth cells 
activity increases in response to inflammatory 
stimuli, and their proliferation increases in the 
healing phase, as can be expected given the role 
they play in driving the growth and intestinal 
tropism in response to injury [158].
It can be assumed that the physiological 
immaturity of the Paneth cell, rather than a 
pathological malfunction, can predispose to 
dysbiosis, and therefore to NEC. This does not 
mean that it is hypo-responsive to stimuli: the 
transcriptional activity is correct, and the granules 
containing antimicrobial peptides are secreted 
normally, as shown by Salzman [159].
The Paneth cells maturation delay is considered 
to be a cause of NEC only in Coutinho’s work, 
conducted on autoptic or surgical specimen by 
NEC children at surgical stage, in gestational age 
between 32 and 42 weeks. Those are compared 
with babies operated for other reasons as intestinal 
atresia [160]. In this case it is highlighted a reduced 
production of lysozyme by the cell of the Paneth.
However, some doubts still remain: in this 
study 60% of cases are full-term NEC infants and 
the full-term’s NEC is probably distinct from the 
preterm’s one. In addiction, the lysozyme is not a 
specific marker of the Paneth cells.
Focusing on the Paneth cell for NEC pathogenesis 
means to assume a global involvement of the entire 
ecology of the crypt, and also of the stem cells, 
at least in the short term. It also means to assume 
that, promoting growth and cell refurbishment, it 
would be possible to cure the disease, or at least 
mitigate its deleterious effects.
Further studies are needed to better define and 
characterize the implications of these findings. 
However, this hypothesis opens to interesting 
possibilities for treatment.
For instance, by injecting stem cells from the 
amniotic fluid into the peritoneum of rats suffering 
from NEC, they integrate in the neonatal gut and 
improve intestinal function, control inflammation, 
express genes of the WNT/βcatenin pathway, 
increase the share in the active cell replication and 
reduce the apoptosis [161, 162].
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The breast milk wealth
 
The breast milk is the ideal food for a newborn, 
especially for a premature one. Each component 
that up until now has been studied has highlighted, 
in addition to its nutritive properties, its anti-
inflammatory and pro-maturative effectiveness 
[116]. Its composition is variable, according to the 
person and to the gestational age and varies along the 
week [163, 164]. It contains not only the nutrients 
needed for growth and development, but also 
numerous bioactive factors that, acting in concert, 
contribute to the beneficial effects of breastfeeding. 
The always-growing list of factors found in human 
milk includes hormones, growth factors, cytokines, 
and chemokines, which operate in network producing 
a cascade of effects contributing to the child’s 
harmonious development and the general maturation 
of immune system functions [41, 44, 116]. 
Immunoglobulins, mainly IgA [44, 45], are 
necessary to infant, especially to a premature one, in 
the first weeks of life, when the endogenous production 
is not enough. They promote phagocytosis, and 
modulate local immunity [44, 47, 165]. Lactoferrin 
and lysozyme, antimicrobial peptides, also promoter 
of the Paneth cells, are also present in the breast milk 
[166, 167]. Breast milk is able to induce B cells to 
IgA production, via the IL6 pathway [48]. It also 
has an immunosuppressant action via IL10 [49]. 
Breast milk contains prebiotics, which stimulate the 
commensal flora, but also has its own flora, deriving 
from the maternal intestine with known tolerogenic 
features [165]. In the breast milk are also contained 
bacterial metabolism products, among which SCFA, 
stimulating the intestinal barrier function [165]. 
In breast milk there are a large number of growth 
factors, acting on the crypt cells, and promoting their 
proliferation: EGF, TGFβ1 and TGFβ2 promote 
the development function and the shelter of the 
gastrointestinal mucosa [19].
Finally, breast milk contains pluripotent stem cells, 
which have the capacity to be used by the organism 
[168, 169]. This particular finding is extremely 
interesting, because it provides an additional 
reason for the promotion of breastfeeding as a safe, 
economical, and ready-to-use mean in the prevention 
of inflammatory disease of the preterm’s gut.
Conclusions
The promotion of intestinal health, or of the 
correct trophism, begins outside the uterus and 
requires a series of measures aimed at maintaining 
Embryological development of the intestine and necrotizing enterocolitis
the physiological balance between proliferative and 
inflammatory function, necessary to the intestinal 
defense. From an histological point of view, 
everything passes through the cell of Paneth, which 
governs the health of the crypt, the inflammatory 
response and the intestinal proliferation. 
In preterm infants, protecting gut health means 
investing in the general health, both in the short 
and long term. For its contents in probiotics, stem 
cells, growth factors and cytokines, breast milk is 
a resource not only on a nutritive point of view, 
but above all for active promotion of growth and 
trophic gut, unparalleled in nature. Numerous 
factors related to hospitalization of the infant cannot 
be changed, but the promotion of breastfeeding is 
the most economical, simple and effective way to 
protect the health of the child, and should be the 
first purpose of each neonatal intensive care unit.
Promising therapeutic applications, after the 
onset of NEC, are given both by the discovery of 
the content of stem cells in breast milk, and by the 
healing potential of amniotic fluid, whose general 
profile closely follows that of breast milk.
Abbreviations
Abbreviations are listed in Tab. 2.
Declaration of interest
The Authors declare that there is no conflict of interest.
References
1. Moossavi S. Location-specific effect of microbiota and MyD88-
dependent signaling on Wnt/β-catenin pathway and intestinal stem 
cells. Gut Microbes. 2014,5:11-4.
2. Mshvildadze M, Neu J. The infant intestinal microbiome: Friend or 
foe? Early Hum Dev. 2010;86(S):67-71.
3. Kandasamy J, Huda S, Ambalavanan N, Jilling T. Inflammatory 
signals that regulate intestinal epithelial renewal, differentiation, 
migration and cell death: Implications for necrotizing enterocolitis. 
Pathophysiology. 2014;21:67-80.
4. https://embryology.med.unsw.edu.au/embryology/index.php/
Carnegie_Stage_Comparison, last access: July 27, 2015.
5. Schoenwolf GC, Bleyl SB, Brauer PR, Francis-West PH. Larsen’s 
human embryology (4th ed.). New York; Edinburgh: Churchill 
Livingstone, 2009.
6. Fortier LA. Stem cells: classifications, controversies, and clinical 
applications. Vet Surg. 2005;34(5):415-23.
7. Gehring WJ. The homeobox in perspective. Trends Biochem Sci. 
1992;17(8):277-80.
8. Gehring WJ. Exploring the homeobox. Gene. 1993;135(1-2):215-21. 
16/21
Journal of Pediatric and Neonatal Individualized Medicine • vol. 5 • n. 2 • 2016www.jpnim.com Open Access
De Magistris • Marcialis • Puddu • Dessì • Irmesi • Coni • Fanos
9. Corsetti MT, Briata P, Sanseverino L, Daga A, Airoldi I, Simeone A, 
Palmisano G, Angelini C, Boncinelli E, Corte G. Differential DNA 
binding properties of three human homeodomain proteins. Nucleic 
Acids Res. 1992;20(17):4465-72.
10. Sherwood RI, Chen T-YA, Melton DA. Transcriptional dynamics of 
endodermal organ formation. Dev Dyn. 2009;238:29-42.
11. Noah TK, Donahue B, Shroyer NF. Intestinal development and 
differentiation. Exp Cell Res. 2011;317:2702-10.
12. Sheaffer, K L, and K H Kaestner. Transcriptional Networks in 
Liver and Intestinal Development. Cold Spring Harb Perspect 
Biol. 2012;4(9):a008284. 
13. Kaufman-Francis K, Goh HN, Kojima Y, Studdert JB, Jones V, 
Power MD, Wilkie E, Teber E, Loebel DA, Tam PP. Differential 
response of epiblast stem cells to Nodal and Activin signalling: a 
paradigm of early endoderm development in the embryo. Philos 
Trans R Soc Lond B Biol Sci. 2014;369(1657). 
14. Davis RP, Ng ES, Costa M, Mossman AK, Sourris K, Elefanty 
AG, Stanley EG.Targeting a GFP reporter gene to the MIXL1 
locus of human embryonic stem cells identifies human primitive 
streak-like cells and enables isolation of primitive hematopoietic 
precursors. Blood. 2008;111(4):1876-84.
15. Spence JR, Lauf R, Shroyer NF. Vertebrate intestinal endoderm 
development. Dev Dyn. 2011;240:501-20. 
16. Izzi L, Silvestri C, von Both I, Labbé E, Zakin L, Wrana JL, 
Attisano L. Foxh1 recruits Gsc to negatively regulate Mixl1 
expression during early mouse development. EMBO J. 
2007;26(13):3132-43.
17. Zorn AM, Wells JM. Vertebrate Endoderm Development and 
Organ Formation. Annu Rev Cell Dev Biol. 2009;25:221-51. 
18. Nankervis CA, Giannone PJ, MD, Reber KM, The Neonatal 
Intestinal Vasculature: Contributing Factors to Necrotizing 
Enterocolitis. Semin Perinatol. 2008;32:83-91. 
19. Thomson ABR, Chopra A, Clandinin MT, Freeman H Recent 
advances in small bowel diseases: Part I. World J Gastroenterol. 
2012;18(26):3336-52.
20. Dessimoz J, Opoka R, Kordich JJ, Grapin-Botton A, Wells 
JM. FGF signaling is necessary for establishing gut tube 
domains along the anterior-posterior axis in vivo. Mech Dev. 
2006;123(1):42-55.
21. Klezovitch O, Vasioukhin V. Your Gut Is Right to Turn Left. 
Dev Cell. 2013;26(6):553-4.
22. Shyer AE, Tallinen T, Nerurkar NL, wei Z, Gil ES, Kaplan DL, 
Tabin CJ, Mahadevan L. Villification: how the gut gets its villi. 
Science. 2013;342:212-8.
23. Shyer AE, Huycke TR, Lee C, Mahadevan L, Tabin CJ. Bending 
Gradients. How the Intestinal Stem Cell Gets Its Home. Cell. 
2015;161(3):569-80. 
24. Scoville DH, Sato T, He XC, Li L. Current View: Intestinal Stem 
Cells and Signaling. Gastroenterology. 2008;134(3):849-64. 
25. Ader M, Tanaka EM. Modeling Human Development in 3D 
Culture. Curr Opin Cell Biol. 2014;31:23-8. 
26. http://web.stanford.edu/group/nusselab/cgi-bin/wnt/target_
genes, last access: August 14, 2015.
27. Nigro G, Sansonetti PJ. Microbiota and Gut Stem Cells Cross-
Talks: A New View of Epithelial Homeostasis. Curr Stem Cell 
Rep. 2015;1:48-52.
28. Barker N. Adult intestinal stem cells: Critical drivers of 











Tumor growth factors β/α TGFβ/TGFα
Tumor necrosis factor α TNFα
Nuclear factor NFκB







Caudal type Homeobox 
transcription factor 2 CDX2
Epidermal growth factor EGF
Insulin-like growth factor IGF1
Hepatic growth factor HGF
Cellular 
receptors
Toll like receptor TLR
Nucleotide-binding 
oligomerization domain- NOD












α-Defensine 5, 6 HD5, HD6





Platelet activating factor PAF
Cellules
Crypt base columnar cells CBC




Late-onset sepsis Sepsi LOS
Very/Extremely low birth 
weight VLBW/ELBW
Table 2. Abbreviations used in the text.
17/21
Journal of Pediatric and Neonatal Individualized Medicine • vol. 5 • n. 2 • 2016 www.jpnim.com Open Access
29. Rao JN, Wang J-Y. Intestinal Stem Cells. In: Rao JN, Wang 
J-Y. Regulation of Gastrointestinal Mucosal Growth. San Rafael 
(CA): Morgan & Claypool Life Sciences, 2010. 
30. Clevers HC, Bevins CL. Paneth Cells: Maestros of the Small 
Intestinal Crypts. Annu Rev Physiol. 2013;75:289-311.
31. Carmon KS, Lin Q, Gong X, Thomas A, Liu Q. LGR5 Interacts and 
Cointernalizes with Wnt Receptors To Modulate Wnt/β-Catenin 
Signaling. Molecular and Cellular Biology. 2012;32(11):2054-64. 
32. Itzkovitz S, Blat IC, Jacks T, Clevers H, van Oudenaarden 
A. Optimality in the development of intestinal crypts. Cell. 
2012;148(3):608-19. 
33. Vermeulen L, Snippert HJ. Stem cell dynamics in homeostasis and 
cancer of the intestine. Nature Publishing Group. 2014;14:468-80.
34. Garabedian EM, Roberts LJJ, Mc Nevin MS, Gordon JI. Examining 
the role of Paneth cells in the small intestine by lineage ablation in 
transgenic mice. J Biol Chem. 1997;272(38):23729-40. 
35. Shroyer NF, Wallis D, Venken KJ, Bellen HJ, Zoghbi HY. Gfi1 
functions downstream of Math1 to control intestinal secretory cell 
subtype allocation and differentiation. Genes Dev. 2005;19(20): 
2412-7. 
36. Bastide P, Darido C, Pannequin J, Kist R, Robine S, Marty-
Double C, Bibeau F, Scherer G, Joubert D, Hollande F, Blache 
P, Jay P. Sox9 regulates cell proliferation and is required for 
Paneth cell differentiation in the intestinal epithelium. J Cell Biol. 
2007;178(4):635-48. 
37. Mori-Akiyama Y, van den Born M, van Es JH, Hamilton SR, Adams 
HP, Zhang J, Clevers H, de Crombrugghe B. SOX9 is required 
for the differentiation of Paneth cells in the intestinal epithelium. 
Gastroenterology. 2007;133(2):539-46.
38. Neu J, Douglas Escobar M. Gastrointestinal development: 
implications for infant feeding. In: Duggan C (Ed.). Nutrition in 
pediatrics, 4th ed. Hamilton, ON, Canada: BC Decker Inc, 2008.
39. Good M, Siggers RH, Sodhi CP, Afrazi A, Alkhudari F, Egan CE, 
Neal MD, Yazji I, Jia H, Lin J, Branca MF, Ma C, Prindle T, Grant 
Z, Shah S, Slagle D 2nd,Paredes J, Ozolek J, Gittes GK, Hackam 
DJ. Amniotic fluid inhibits Toll-like receptor 4 signaling in the 
fetal and neonatal intestinal epithelium. Proc Natl Acad Sci U S A. 
2012;109(28):11330-5. 
40. Young BK, Chan MK, Liu L, Basch RS. Amniotic fluid as a source 
of multipotent cells for clinical use. J Perinat Med. 2016;44(3):333-7.
41. Hirai C, Ichiba H, Saito M, Shintaku H, Yamano T, Kusuda S. 
Trophic effect of multiple growth factors in amniotic fluid or 
human milk on cultured human fetal small intestinal cells. J Pediatr 
Gastroenterol Nutr. 2002;34(5):524-8.
42. Wolfs TGAM, Kramer BW, Thuijls G, Kemp MW, Saito M, Willems 
MGM, Senthamarai-Kannan P, Newnham JP, Jobe AH, Kallapur 
SG. Chorioamnionitis-induced fetal gut injury is mediated by direct 
gut exposure of inflammatory mediators or by lung inflammation. 
Am J Physiol Gastrointest Liver Physiol. 2014;306:G382-93.
43. Siggers RH, Siggers J, Thymann T, Boye M, Sangild PT. Nutritional 
modulation of the gut microbiota and immune system in preterm 
neonates susceptible to necrotizing enterocolitis. J Nutr Biochem. 
2011:22:511-21.
44. Lawrence RM, Pane CA. Human breast milk: current concepts of 
immunology and infectious diseases. Curr Probl Pediatr Adolesc 
Health Care. 2007;37:7-36.
45. Chirico G, Marzollo R, Cortinovis S, Fonte C, Gasparoni A. Anti-
infective properties of human milk. J Nutr. 2008;138:S1801-6.
46. Goldman AS. The immune system in human milk and the developing 
infant. Breastfeed Med. 2007;2:195-204.
47. Bollinger RR, Everett ML, Palestrant D, Love SD, Lin SS, Parker 
W. Human secretory immunoglobulin A may contribute to biofilm 
formation in the gut. Immunology. 2003;109:580-7.
48. Saito S, Maruyama M, Kato Y, Moriyama I, Ichijo M. Detection of 
IL-6 in human milk and its involvement in IgA production. J Reprod 
Immunol. 1991;20:267-76.
49. Brandtzaeg P, Farstad IN, Johansen F-E, Morton HC, Norderhaug 
IN, Yamanaka T. The B-cell system of human mucosae and exocrine 
glands. Immunol Rev. 1999;171:45-87.
50. Field CJ. The immunological components of human milk and their 
effect on immune development in infants. J Nutr. 2005;135:1-4.
51. Neu J. Developmental aspects of maternal-fetal, and infant gut 
microbiota and implications for long-term health. Matern Health 
Neonatol Perinatol. 2015;1:6-7.
52. Natividad JMM, Verdu EF. Modulation of intestinal barrier by 
intestinal microbiota: Pathological and therapeutic implications. 
Pharmacol Res. 2013;69:42-51
53. Emami CM, Petrosyan M, Giuliani S, Williams M, Hunter C, 
Prasadarao, NV, Ford HR. Role of the Host Defense System and 
Intestinal Microbial Flora in the Pathogenesis of Necrotizing 
Enterocolitis. Surg Infect (Larchmt). 2009:10(5):407-17.
54. Li M, Wang B, Zhang M, Rantalainen M, Wang S, Zhou H, Zhang 
Y, Shen J, Pang X, Zhang M, Wei H, Chen Y, Lu H, Zuo J, Su 
M, Qiu Y, Jia W, Xiao C, Smith LM, Yang S, Holmes E, Tang 
H, Zhao G, Nicholson JK, Li L, Zhao L. Symbiotic gut microbes 
modulate human metabolic phenotypes. Proc Natl Acad Sci USA. 
2008;105(6):2117-22.
55. Duerkop BA, Vaishnava S, Hooper LV. Immune responses to the 
microbiota at the intestinal mucosal surface. Immunity. 2009;31: 
368-76.
56. Konrad D, Wueest S. The gut-adipose-liver axis in the metabolic 
syndrome. Physiology (Bethesda). 2014;29:304-13.
57. Bevins CL, Salzman NH. Paneth cells, antimicrobial peptides 
and maintenance of intestinal homeostasis. Nat Rev Microbiol. 
2011;9(5):356-68.
58. Pédron T1, Mulet C, Dauga C, Frangeul L, Chervaux C, Grompone 
G, Sansonetti PJ. A crypt-specific core microbiota resides in the 
mouse colon. MBio. 2012;3(3):e00116-12. 
59. Belkaid Y, Hand TW. Role of the microbiota in immunity and 
inflammation. Cell. 2014;157(1):121-41.
60. Escobedo G, López-Ortiz E, Torres-Castro I. Gut microbiota as a 
key player in triggering obesity, systemic inflammation and insulin 
resistance. Rev Invest Clin. 2014;66:450-9.
61. Lahra MM, Jeffery HE. A fetal response to chorioamnionitis is 
associated with early survival after preterm birth. Am J Obstet 
Gynecol. 2004;190:147-51.
Embryological development of the intestine and necrotizing enterocolitis
18/21
Journal of Pediatric and Neonatal Individualized Medicine • vol. 5 • n. 2 • 2016www.jpnim.com Open Access
De Magistris • Marcialis • Puddu • Dessì • Irmesi • Coni • Fanos
62. Hitti J, Tarczy-Hornoch P, Murphy J, Hillier SL, Aura J, Eschenbach 
DA. Amniotic fluid infection, cytokines, and adverse outcome among 
infants at 34 weeks’ gestation or less. Obstet Gynecol. 2001;98: 
1080-8. 
63. Thompson-Chagoyan OC, Maldonado J, Gil A. Colonization and 
impact of disease and other factors on intestinal microbiota. Dig Dis 
Sci. 2007;52:2069-77. 
64. Bezirtzoglou E. The intestinal microflora during the first weeks of 
life. Anaerobe.1997;3:173-7.
65. Palmer C, Bik EM, DiGiulio DB, Relman DA, Brown PO. 
Development of the human infant intestinal microbiota. PLoS Biol. 
2007;5:e177.
66. Favier CF, Vaughan EE, DeVos WM, Akkermans AD. Molecular 
monitoring of succession of bacterial communities in human 
neonates. Appl Environ Microbiol. 2002;68:219-26.
67. Adlerberth I, Lindberg E, Aberg N, Hesselmar B, Saalman R, 
Strannegård IL, Wold AE. Reduced enterobacterial and increased 
staphylococcal colonization of the infantile bowel: an effect of 
hygienic lifestyle? Pediatr Res. 2006;59:96-101.
68. Balmer SE, Scott PH, Wharton BA. Diet and faecal flora in the 
newborn: casein and whey proteins. Arch Dis Child. 1989;64: 
1678-84.
69. Hunter CJ, Upperman JS, Ford HR, Camerini V. Understanding the 
Susceptibility of the Premature Infant to Necrotizing Enterocolitis 
(NEC). Pediatr Res. 2008;63(2):117-123.
70. Muresan Z, Paul DL, Goodenough DA. Occludin 1B, a variant of 
the tight junction protein occludin. Mol Biol Cell. 2000;11:627-34.
71. Elphick DA, Mahida YR. Paneth cells: their role in innate immunity 
and inflammatory disease. Gut. 2005;54:1802-9.
72. Chaaban, H Stonestreet BS. Intestinal Hemodynamics and 
Oxygenation in the Perinatal Period. Semin Perinatol. 2012;36:260-8.
73. Deplancke B, Gaskins HR. Microbial modulation of innate defense: 
goblet cells and the intestinal mucus layer. Am J Clin Nutr. 
2001;73:1131S-41S.
74. Zouali H, Bonnard A, De Lagausie DL, Farnoux C, Aigrain Y, 
Cezard JP, Peuchmaur M, Hugot JP, Berrebi D. CARD15/NOD2 is 
not a predisposing factor for necrotizing enterocolitis. Dig Dis Sci. 
2005;50(9):1684-7.
75. Richardson WM, Sodhi CP, Russo A, Siggers RH, Afrazi A, Gribar 
SC, Neal MD,Dai S, Prindle T Jr, Branca M, Ma C, Ozolek J, Hackam 
DJ. Nucleotide-binding oligomerization domain-2 inhibits toll-like 
receptor-4 signaling in the intestinal epithelium. Gastroenterology. 
2010;139(3):904-17, 917.e1-6.
76. Bartolozzi G. La funzione dei toll-like receptor. Medico e Bambino 
pagine elettroniche 2007; 10(1) http://www.medicoebambino.com/_
like_toll_recettori_cellule_tlr_malattia
77. Amin Afrazi A, Sodhi CP, Richardson W, Neal M, Good M, Siggers 
R, Hackam DJ. New Insights Into the Pathogenesis and Treatment of 
Necrotizing Enterocolitis: Toll-Like Receptors and Beyond. Pediatr 
Res. 2011;69:183-8.
78. Soliman A, Michelsen KS, Karahashi H, Lu J, Meng FJ, Qu X, 
Crother TR,Rabizadeh S, Chen S, Caplan MS, Arditi M, Jilling 
T. Platelet-activating factorinduces TLR4 expression in intestinal 
epithelial cells: implication for the pathogenesis of necrotizing 
enterocolitis. PLoS One. 2010;5(10):e15044.
79. Pal D, Dasgupta S, Kundu R, Maitra S, Das G, Mukhopadhyay S, Ray 
S, Majumdar SS, Bhattacharya S. Fetuin-A acts as an endogenous 
ligand of TLR4 to promote lipid-induced insulin resistance. Nat Med. 
2012;18(8):1279-85.
80. Gribar SC, Sodhi CP, Richardson WM, Anand RJ, Gittes GK, Branca 
MF, Jakub A, Shi XH, Shah S, Ozolek JA, Hackam DJ Reciprocal 
expression and signaling of TLR4 and TLR9 in the pathogenesis and 
treatment of necrotizing enterocolitis. J Immunol. 2009;182:636-46.
81. Muguruma K, Gray PW, Tjoelker LW, Johnston JM. The central role 
of PAF in necrotizing enterocolitis development. Adv Exp Med Biol. 
1997;407:379-82.
82. Amer MD, Hedlund E, Rochester J, Caplan MS. Platelet-activating 
factor concentration in the stool of human newborns: effects of 
enteral feeding and neonatal necrotizing enterocolitis. Biol Neonate. 
2004;85:159-66.
83. Siggers RH, Siggers J, Thymann T, Boye M, Sangild PT, Nutritional 
modulation of the gut microbiota and immune system in preterm 
neonates susceptible to necrotizing enterocolitis. J Nut Bio. 
2011;22:511-21.
84. Keshav S. Paneth cells: leukocyte-like mediators of innate immunity 
in the intestine. J Leukoc Biol. 2006;80(3):500-8. 
85. McElroy SJ, Underwood MA, Sherman MP. Paneth cells and 
necrotizing enterocolitis: a novel hypothesis for disease pathogenesis. 
Neonatology. 2013;103:10-20.
86. Wehkamp J, Koslowski M, Wang G, Stange EF. Barrier dysfunction 
due to distinct defensin deficiencies in small intestinal and colonic 
Crohn’s disease. Mucosal Immunol. 2008;1(Suppl 1):S67-74.  
87. Petnicki-Ocwieja T, Hrncir T, Liu YJ, Biswas A, Hudcovic T, 
Tlaskalova-Hogenova H, Kobayashi KS. Nod2 is required for the 
regulation of commensal microbiota in the intestine. Proc Natl Acad 
Sci U S A. 2009;106(37):15813-8.  
88. Kobayashi KS, Chamaillard M, Ogura Y, Henegariu O, 
Inohara N, Nuñez G, Flavell RA. Nod2-dependent regulation 
of innate and adaptive immunity in the intestinal tract. Science. 
2005;307(5710):731-4.  
89. Stappenbeck TS, Hooper LV, Gordon JI. Developmental regulation 
of intestinal angiogenesis by indigenous microbes via Paneth cells. 
Proc Natl Acad Sci U S A. 2002;99:15451-5.  
90. Salzman NH, Polin RA, Harris MC, Ruchelli E, Hebra A, Zirin-
Butler S, Jawad A,Martin Porter E, Bevins CL. Enteric defensin 
expression in necrotizing enterocolitis. Pediatr Res. 1998;44(1):20-6. 
91. Mallow EB, Harris A,N, Russell JP, DeBerardinis RJ, Ruchelli 
E, Bevins CL. Human enteric defensins. Gene structure and 
developmental expression. J Biol Chem. 1996;271(8):4038-45.
92. Schumann A, Nutten S, Donnicola D, Comelli EM, Mansourian 
R, Cherbut C, Corthesy-Theulaz I, Garcia-Rodenas C. Neonatal 
antibiotic treatment alters gastrointestinal tract developmental gene 
expression and intestinal barrier transcriptome. Physiol Genomics. 
2005;23(2):235-45.
93. Wehkamp J, Stange EF. Paneth cells and the innate immune response. 
Curr Opin Gastroenterol. 2006;22(6):644-50.
19/21
Journal of Pediatric and Neonatal Individualized Medicine • vol. 5 • n. 2 • 2016 www.jpnim.com Open Access
94. Darfeuille-Michaud A, Neut C, Barnich N, Lederman E, Di 
Martino P, Desreumaux P, Gambiez L, Joly B, Cortot A, Colombel 
JF. Presence of adherent Escherichia coli strains in ileal mucosa 
of patients with Crohn’s disease. Gastroenterology. 1998;115(6): 
1405-13. 
95. Darfeuille-Michaud A, Boudeau J, Bulois P, Neut C, Glasser AL, 
Barnich N, Bringer MA, Swidsinski A, Beaugerie L, Colombel 
JF. High prevalence of adherent-invasive Escherichia coli 
associated with ileal mucosa in Crohn’s disease. Gastroenterology. 
2004;127(2):412-21. 
96. Swidsinski A, Ladhoff A, Pernthaler A, Swidsinski S, Loening-
Baucke V, Ortner M, Weber J, Hoffmann U, Schreiber S, Dietel 
M, Lochs H. Mucosal flora in inflammatory bowel disease. 
Gastroenterology. 2002;122(1):44-54. 
97. Meslin JC, Fontaine N, Andrieux C. Variation of mucin distribution 
in the rat intestine, caecum and colon: effect of the bacterial flora. 
Comp Biochem Physiol A Mol Integr Physiol. 1999;123(3):235-9. 
98. Gordon HA, Bruckner-Kardoss E. Effect of normal microbial flora 
on intestinal surface area. Am J Physiol. 1961;201:175-8. 
99. Abrams GD, Bauer H, Sprinz H. Influence of the normal flora 
on mucosal morphology and cellular renewal in the ileum. A 
comparison of germ-free and conventional mice. Lab Investig. 
1963;12:355-64. 
100. Smith K, McCoy KD, Macpherson AJ. Use of axenic animals in 
studying the adaptation of mammals to their commensal intestinal 
microbiota. Semin Immunol. 2007;19(2):59-69.  
101. Hooper LV, Wong MH, Thelin A, Hansson L, Falk PG, Gordon JI. 
Molecular analysis of commensal host–microbial relationships in 
the intestine. Science. 2001;291:881-4.  
102. Chow J, Lee SM, Shen Y, Khosravi A, Mazmanian SK. Host-
bacterial symbiosis in health and disease. Adv Immunol. 
2010;107:243-74. 
103. Kawai T, Akira S. Toll-like receptors and their crosstalk with 
other innate receptors in infection and immunity. Immunity. 
2011;34:637-50. 
104. Escobedo G, López-Ortiz E, Torres-Castro I. Gut microbiota as a 
key player in triggering obesity, systemic inflammation and insulin 
resistance. Rev Invest Clin. 2014;66:450-9.
105. Cani PD, Possemiers S, Van de Wiele T, Guiot Y, Everard A, Rottier 
O, Geurts L, Naslain D, Neyrinck A, Lambert DM, Muccioli GG, 
Delzenne NM. Changes in gut microbiota control inflammation 
in obese mice through a mechanism involving GLP-2-driven 
improvement of gut permeability. Gut. 2009;58(8):1091-103. 
106. Madara JL, Stafford J. Interferon-gamma directly affects barrier 
function of cultured intestinal epithelial monolayers. J Clin Invest. 
1989;83(2):724-7.  
107. Wirtz S, Neufert C, Weigmann B, Neurath MF. Chemically induced 
mouse models of intestinal inflammation. Nat Protoc. 2007;2: 
541-6.  
108. Berkes J, Viswanathan VK, Savkovic SD, Hecht G. Intestinal 
epithelial responses to enteric pathogens: effects on the tight 
junction barrier, ion transport, and inflammation. Gut. 2003;52: 
439-51.  
109. Turner JR. Intestinal mucosal barrier function in health and disease. 
Nat Rev Immunol. 2009;9:799-809. 
110. Spiller RC, Jenkins D, Thornley JP, Hebden JM, Wright T, 
Skinner M, et al. Increased rectal mucosal enteroendocrine cells, 
T lymphocytes, and increased gut permeability following acute 
Campylobacter enteritis and in post- dysenteric irritable bowel 
syndrome. Gut. 2000;47:804-11. 
111. Zocco MA, Ainora ME, Gasbarrini G, Gasbarrini A. Bacteroides 
thetaiotaomicron in the gut: Molecular aspects of their interaction. 
Dig Liver Dis. 2007;39(8):707-12. 
112. Pull SL, Doherty JM, Mills JC, Gordon JI, Stappenbeck TS. 
Activated macrophages are an adaptive element of the colonic 
epithelial progenitor niche necessary for regenerative responses to 
injury. Proc Natl Acad Sci U S A. 2005;102:99-104.
113. Neal MD, Sodhi CP, Jia H, Dyer M, Egan CE, Yazji I, Good M, 
Afrazi A, Marino R, Slagle D, Ma C, Branca MF, Prindle T Jr, 
Grant Z, Ozolek J, Hackam DJ. Toll-like receptor 4 is expressed on 
intestinal stem cells and regulates their proliferation and apoptosis 
via the p53 up-regulated modulator of apoptosis. J Biol Chem. 
2012;287(44):37296-308. 
114. Indrio F, Neu J. The intestinal microbiome of infants and the use of 
probiotics Curr Opin Pediatr. 2011;23(2):145-150. 
115. Downard CD, Grant SN, Matheson PJ, Guillaume AW, Debski R, 
Fallat ME, Garrison RN. Altered intestinal microcirculation is the 
critical event in the development of necrotizing enterocolitis. J Ped 
Surg. 2011;46:1023-8
116. Chatterton DEW, Nguyen DN, Bering SB, Sangild PT. Anti-
inflammatory mechanisms of bioactive milk proteins in the intestine 
of newborns. Int J Biochem Cell Biol. 2013;45:1730-47.
117. Underwood MA. Paneth cells and necrotizing enterocolitis. Gut 
Microbes. 2012;3(6):562-5. 
118. Been JV, Lievense S, Zimmermann LJI, Kramer, MD, Wolfs TG. 
Chorioamnionitis as a Risk Factor for Necrotizing Enterocolitis: A 
Systematic Review and Meta-Analysis. J Pediatr. 2013;162:236-42.
119. Poroyko V, Morowitz M, Bell T, Ulanov A, Wang M, Donovan 
S, Bao N, Gu S, Hong L, Alverdy JC, Bergelson J, Liu DC. Diet 
creates metabolic niches in the “immature gut” that shape microbial 
communities. Nutr Hosp. 2011;26(6):1283-95.
120. Peter CS, Feuerhahn M, Bohnhorst B, Schlaud M, Ziesing S, von der 
Hardt H, Poets CF. Necrotising enterocolitis: is there a relationship to 
specific pathogens? Eur J Pediatr. 1999;158:67-70.
121. Wang Y, Hoenig JD, Malin KJ, Qamar S, Petrof EO, Sun J, 
Antonopoulos DA, Chang EB, Claud EC. 16S rRNA gene-based 
analysis of fecal microbiota from preterm infants with and without 
necrotizing enterocolitis. ISME J. 2009;3(8):944-54. 
122. Mai V, Young CM, Ukhanova M, Wang X, Sun Y, Casella G, 
Theriaque D, Li N, Sharma R, Hudak M, Neu J. Fecal Microbiota 
in Premature Infants Prior to Necrotizing Enterocolitis. PLoS One. 
2011;6(6):e20647. 
123. Stoll B, Chang XY, Fan MZ, Reeds PJ, Burrin DG. Enteral nutrient 
intake level determines intestinal protein synthesis and accretion 
rates in neonatal pigs. Am J Physiol Gastrointest Liver Physiol. 
2000;279:G288-94.
Embryological development of the intestine and necrotizing enterocolitis
20/21
Journal of Pediatric and Neonatal Individualized Medicine • vol. 5 • n. 2 • 2016www.jpnim.com Open Access
De Magistris • Marcialis • Puddu • Dessì • Irmesi • Coni • Fanos
124. Shulman RJ. Effect of different total parenteral-nutrition fuel mixes 
on small intestinal growth and differentiation in the infant miniature 
pig. Gastroenterology. 1988;95:85-92.
125. Ferguson A. Immunological functions of the gut in relation to 
nutritional state and mode of delivery of nutrients. Gut. 1994;35: 
S10-2.
126. Neu J. Gastrointestinal development and meeting the nutritional 
needs of premature infants. Am J Clin Nutr. 2007;85:629S-34S.
127. Bjornvad CR, Thymann T, Deutz NE, Burrin DG, Jensen SK, 
Jensen BB, Mølbak L, Boye M, Larsson LI, Schmidt M, Michaelsen 
KF, Sangild PT. Enteral feeding induces diet-dependent mucosal 
dysfunction, bacterial proliferation, and necrotizing enterocolitis in 
preterm pigs on parenteral nutrition. Am J Physiol Gastrointest Liver 
Physiol. 2008;295:G1092-103.
128. Kudsk KA. Current aspects of mucosal immunology and its influence 
by nutrition. Am J Surg. 2002;183:390-8.
129. Burrin DG, Stoll B, Jiang RH, Chang XY, Hartmann B, Holst JJ, 
Greeley GH Jr, Reeds PJ. Minimal enteral nutrient requirements for 
intestinal growth in neonatal piglets: how much is enough? Am J Clin 
Nutr. 2000;71(6):1603-10.
130. Meinzen-Derr J, Poindexter B, Wrage L, Morrow I, Stoll B, Donovan 
EF. Role of human milk in extremely low birth weight infants’ risk of 
necrotizing enterocolitis or death. J Perinat. 2009;29:57-62. 
131. Morgan JA, Young L, McGuire W. Pathogenesis and prevention of 
necrotizing enterocolitis. Curr Opin Infect Dis. 2011;24(3):183-9.
132. Gordon PV, Swanson JR, Attridge JT, Clark R. Emerging trends 
in acquired neonatal intestinal disease: is it time to abandon Bell’s 
criteria? J Perinat. 2007:27:661-71. 
133. Saric J, Wang Y, Li J, Coen M, Utzinger J, Marchesi JR, Keiser J, 
Veselkov K, Lindon JC, Nicholson JK, Holmes E. Species variation 
in the fecal metabolome gives insight into differential gastrointestinal 
function. J Proteome Res. 2008;7(1):352-60.
134. Mannoia K, Boskovic DS, Slater L, Plank MS, Angelesc DM, 
Gollina G. Necrotizing enterocolitis is associated with neonatal 
intestinal injury. J Ped Surg. 2011:46:81-5.
135. Thompson A, Bizzarro M, Yu S, Diefenbach K, Simpson BJ, Moss 
RL. Risk factors for necrotizing enterocolitis totalis: a case-control 
study. J Perinatol. 2011;31(11):730-8.
136. Bolisetty S, Lui K, Oei J, Wojtulewicz J. A regional study of 
underlying congenital diseases in term neonates with necrotizing 
enterocolitis. Acta Paediatr. 2000;89:1226-30.
137. Peter CS, Feuerhahn M, Bohnhorst B, Schlaud M, Ziesing S, von der 
Hardt H, Poets CF. Necrotising enterocolitis: is there a relationship to 
specific pathogens? Eur J Pediatr. 1999;158:67-70.
138. Wang Y, Hoenig JD, Malin KJ, Qamar S, Petrof EO, Sun J, 
Antonopoulos DA, Chang EB, Claud EC. 16S rRNA gene-based 
analysis of fecal microbiota from preterm infants with and without 
necrotizing enterocolitis. ISME J. 2009:3:944-54. 
139. Munford RS, Varley AW. Shield as signal: lipopolysaccharides and 
the evolution of immunity to gram-negative bacteria. PLoS Pathog. 
2006;2:e67.
140. Coats SR, Do CT, Karimi-Naser LM, Braham PH, Darveau RP. 
Antagonistic lipopolysaccharides block E. coli lipopolysaccharide 
function at human TLR4 via interaction with the human MD-2 
lipopolysaccharide binding site. Cell Microbiol. 2007;9:1191-202.
141. Wynn J, Cornell TT, Wong HR, Shanley TP, Wheeler DS. The 
host response to sepsis and developmental impact. Pediatrics. 
2010;125:1031-41
142. Cilieborg MS, Boye M, Mølbak L, Thymann T, Sangild PT. Preterm 
Birth and Necrotizing Enterocolitis Alter Gut Colonization in Pigs. 
Pediatr Res. 2011;69:10-6.
143. Leaphart CL, Cavallo JC, Gribar SC, Cetin S, Li J, Branca MF, 
Dubowski TD, Sodhi CP, Hackam DJ. A critical role for TLR4 in 
the pathogenesis of necrotizing enterocolitis by modulating intestinal 
injury and repair. J Immunol. 2007;179(7):4808-20. 
144. Mai V, Torrazza RM, Ukhanova M, Wang X, Sun Y, Li N, Shuster 
J, Sharma R, Hudak ML, Neu J. Distortions in Development of 
Intestinal Microbiota Associated with Late Onset Sepsis in Preterm 
Infants. PLoS One. 2013;8(1):e52876. 
145. Sodhi CP, Shi XH, Richardson WM, Grant ZS, Shapiro RA, Prindle 
TJ, Branca M, Russo A, Gribar SC, Ma C, Hackam DJ. Toll-like 
receptor-4 inhibits enterocyte proliferation via impaired beta-
catenin signaling in necrotizing enterocolitis. Gastroenterology. 
2010;138:185-96. 
146. Hitti J, Tarczy-Hornoch P, Murphy J, Hillier SL, Aura J, Eschenbach 
DA. Amniotic fluid infection, cytokines, and adverse outcome among 
infants at 34 weeks’ gestation or less. Obstet Gynecol. 2001;98:1080-
8. 
147. DiGiulio DB, Romero R, Kusanovic JP, Gómez R, Kim CJ, Seok 
KS, Gotsch F, Mazaki-Tovi S, Vaisbuch E, Sanders K, Bik EM, 
Chaiworapongsa T, Oyarzún E, Relman DA. Prevalence and 
diversity of microbes in the amniotic fluid, the fetal inflammatory 
response, and pregnancy outcome in women with preterm pre-labor 
rupture of membranes. Am J Reprod Immunol. 2010;64(1):38-57.
148. Lahra MM, Jeffery HE. A fetal response to chorioamnionitis is 
associated with early survival after preterm birth. Am J Obstet 
Gynecol. 2004;190:147-51. 
149. Goepfert AR, Andrews WW, Carlo W, Ramsey PS, Cliver SP, 
Goldenberg RL, Hauth JC. Umbilical cord plasma interleukin-6 
concentrations in preterm infants and risk of neonatal morbidity. Am 
J Obstet Gynecol. 2004;191:1375-81.
150. Satar M, Turhan E, Yapicioglu H, Narli N, Ozgunen FT, Cetiner 
S. Cord blood cytokine levels in neonates born to mothers with 
prolonged premature rupture of membranes and its relationship with 
morbidity and mortality. Eur Cytokine Netw. 2008;19:37-41.
151. Tanner SM, Berryhill TF, Ellenburg JL, Jilling T, Cleveland DS, 
Lorenz RG, Martin CA. Pathogenesis of Necrotizing Enterocolitis 
Modeling the Innate Immune Response. Am J Pathol. 2015;185:4-16.
152. González-Rivera R, Culverhouse RC, Hamvas A, Tarr PI, Warner 
BB. The Age of Necrotizing Enterocolitis Onset: An Application of 
Sartwell’s Incubation Period Model. J Perinatol. 2011;31(8):519-23.
153. Maynard AA, Dvorak K, Khailova L, Dobrenen H, Arganbright KM, 
Halpern MD, Kurundkar AR, Maheshwari A, Dvorak B. Epidermal 
growth factor reduces autophagy in intestinal epithelium and in the 
rat model of necrotizing enterocolitis. Am J Physiol Gastrointest 
Liver Physiol. 2010;299:G614-22. 
21/21
Journal of Pediatric and Neonatal Individualized Medicine • vol. 5 • n. 2 • 2016 www.jpnim.com Open Access
154. Raaberg L, Nexø E, Damsgaard Mikkelsen J, Seier Poulsen S. 
Immunohistochemical localisation and developmental aspects of 
epidermal growth factor in the rat. Histochemistry. 1988;89:351-6. 
155. Thachil E, Hugot JP, Arbeille B, Paris R, Grodet A, Peuchmaur M, 
Codogno P, Barreau F, Ogier-Denis E, Berrebi D, Viala J. Abnormal 
activation of autophagy-induced crinophagy in Paneth cells from 
patients with Crohn’s disease. Gastroenterology. 2012;142:1097– 
1099.e4. 
156. Bauer CR, Morrison JC, Poole WK, Korones SB, Boehm JJ, Rigatto 
H, Zachman RD. A decreased incidence of necrotizing enterocolitis 
after prenatal glucocorticoid therapy. Pediatrics. 1984;73:682-8. 
157. Coutinho VB, Coutinho HB, Coutinho EM. Effects of hydrocortisone 
acetate treatment on the small intestine of the lactent marsupial 
Didelphis albiventris. Anat Anz. 1991;172:213-21.  
158. Puiman PJ, Burger-Van Paassen N, Schaart MW, De Bruijn ACJM, 
De Krijger RR, Tibboel D, Van Goudoever JB, Renes IB. Paneth cell 
hyperplasia and metaplasia in necrotizing enterocolitis. Pediatr Res. 
2011;69:217-23
159.  Salzman NH, Polin RA, Harris MC, Ruchelli E, Hebra A, Zirin-
Butler S, Jawad A, Martin Porter E, Bevins CL. Enteric defensin 
expression in necrotizing enterocolitis. Pediatr Res. 1998;44(1):20-6. 
160. Coutinho HB, da Mota HC, Coutinho VB, Robalinho TI, Furtado 
AF, Walker E, King G, Mahida YR, Sewell HF, Wakelin D. Absence 
of lysozyme (muramidase) in the intestinal Paneth cells of newborn 
infants with necrotising enterocolitis. J Clin Pathol. 1998;51:512-4.
161. Zani A, Cananzi M, Fascetti-Leon F, Lauriti G, Smith VV, Bollini S, 
Ghionzoli M, D’Arrigo A, Pozzobon M, Piccoli M, Hicks A, Wells J, 
Siow B, Sebire NJ, Bishop C, Leon A, Atala A, Lythgoe MF, Pierro 
A, Eaton S, De Coppi P. Amniotic fluid stem cells improve survival 
and enhance repair of damaged intestine in necrotising enterocolitis 
via a COX-2 dependent mechanism. 2014;63(2):300-9.
162. Tayman C, Uckan D, Kilic E, Ulus AT, Tonbul A, Murat Hirfanoglu 
I, Helvacioglu F, Haltas H, Koseoglu B, Tatli MM. Mesenchymal 
Embryological development of the intestine and necrotizing enterocolitis
stem cell therapy in necrotizing enterocolitis: a rat study. Pediatr Res. 
2011;70(5):489-94. 
163. Cesare Marincola F, Noto A, Caboni P, Reali A, Barberini L, Lussu 
M Murgia F Santoru ML, Atzori L, Fanos V A metabolomic study 
of preterm human and formula milk by high resolution NMR and 
GC/MS analysis: preliminary results J Matern Fetal Neonatal Med, 
2012;25(S5):62-7.
164. Castellote C, Casillas R Ramırez-Santana C, Perez-Cano FJ, 
Castell M, Moretones MG, Lopez-Sabater C, Franch A. Premature 
Delivery Influences the Immunological Composition of Colostrum 
and Transitional and Mature Human Milk. J Nutr. 2011;141(6): 
1181-7. 
165. Gordon PV. Necrotizing Enterocolitis (NEC) and Darwinism 
(Reviewing the Evolutionary Basis for NEC). EJ Neonatol Res. 
2013;3(1):23-30. 
166. Sherman MP, Adamkin DH, Radmacher PG, Sherman J, Niklas V. 
Protective proteins in mammalian milks: lactoferrin steps forward. 
Neo Rev. 2012;13:e293-e300. 
167. Manzoni P, Rinaldi M, Cattani S, Pugni L, Romeo MG, Messner 
H, Stolfi I, Decembrino L, Laforgia N, Vagnarelli F, Memo L, 
Bordignon L, Saia OS, Maule M, Gallo E, Mostert M, Magnani C, 
Quercia M, Bollani L, Pedicino R, Renzullo L, Betta P, Mosca F, 
Ferrari F, Magaldi R, Stronati M, Farina D; Italian Task Force for the 
Study and Prevention of Neonatal Fungal Infections, Italian Society 
of Neonatology. Bovine lactoferrin supplementation for prevention 
of late-onset sepsis in very low-birth-weight neonates: a randomized 
trial. JAMA. 2009;302:1421-8. 
168. Cregan MD, Fan Y, Appelbee A, Brown ML, Klopcic B, Koppen 
J, Mitoulas LR,Piper KM, Choolani MA, Chong YS, Hartmann PE. 
Identification of nestin-positive putative mammary stem cells in 
human breastmilk. Cell Tissue Res. 2007;329(1):129-36.
169. Walker WA, Iyengar RS. Breast milk, microbiota, and intestinal 
immune homeostasis. Pediatr Res. 2015;77(1-2):220-8. 
